Cleared Traditional

K821669 - AMES TDA GENTAMICIN TEST

K821669 is an FDA 510(k) clearance for AMES TDA GENTAMICIN TEST, manufactured by Miles Laboratories, Inc.. The device is a Class 2 Chemistry device with product code DJB cleared through the Traditional 510(k) pathway after a 191-day FDA review.

K821669 · Miles Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1982
Decision
191d
Days
Class 2
Risk

K821669 is an FDA 510(k) clearance for the AMES TDA GENTAMICIN TEST. Classified as Radioimmunoassay, Gentamicin (125-i), Second Antibody Sep. (product code DJB), Class II - Special Controls.

Submitted by Miles Laboratories, Inc. (Walker, US). The FDA issued a Cleared decision on December 15, 1982 after a review of 191 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3450 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Miles Laboratories, Inc. devices

FDA 510(k) Submission Details - K821669

510(k) Number K821669 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 1982
Decision Date December 15, 1982
Days to Decision 191 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
103d slower than avg
Panel avg: 88d · This submission: 191d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DJB Device Classification - Class 2, Special Controls

Product Code DJB Radioimmunoassay, Gentamicin (125-i), Second Antibody Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3450
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DJB Radioimmunoassay, Gentamicin (125-i), Second Antibody Sep.

All 15
Devices cleared under the same product code (DJB) and FDA review panel - the closest regulatory comparables to K821669.
AMES TDA SISOMICIN TEST-CONTROL SERUM
K832792 · Miles Laboratories, Inc. · Sep 1983
GENTAMICIN TEST PACK-ACA
K831210 · E.I. Dupont DE Nemours & Co., Inc. · May 1983
COAT-A-COUNT GENTAMICIN RIA KIT
K811844 · Diagnostic Products Corp. · Jul 1981
QUANTIMUNE GENTAMICIN RIA GENTAMICIN
K791770 · Bio-Rad · Oct 1979
FLUOROMATIC GENTAMICIN FIA IMMUNOASSAY
K791547 · Bio-Rad · Oct 1979
BIOASSAY SYSTEM, MS-2 SERUM
K782049 · Abbott Laboratories · Aug 1979